Aska Pharmaceutical Company Limited operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Aska Pharmaceutical Company Limited with three other
companies in this sector in JAPAN :
Kissei Pharmaceutical Company Limited
sales of 63.23 billion Japanese Yen [US$598.19 million]
of which 81%
was Pharmaceutical Products),
Zeria Pharmaceutical Co Ltd
(60.43 billion Japanese Yen [US$571.64 million]
of which 53%
was Pharmaceuticals Business), and
Fuso Pharmaceutical Industries Ltd
(46.90 billion Japanese Yen [US$443.68 million]
of which 100%
Aska Pharmaceutical Company Limited reported sales of ¥52.54 billion (US$497.05 million)
March of 2020.
increase of 12.5%
versus 2019, when the company's sales were ¥46.71 billion.
Sales of Pharmaceutical Products Business saw an increase
14.6% in 2020, from
¥41.76 billion to ¥47.85 billion.
Not all segments of Aska Pharmaceutical Company Limited experienced an increase in sales in 2020:
sales of Other fell 5.2% to ¥4.69 billion.